A detailed history of Marshall Wace, LLP transactions in Utah Medical Products Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 4,831 shares of UTMD stock, worth $304,111. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,831
Holding current value
$304,111
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$65.79 - $75.08 $317,831 - $362,711
4,831 New
4,831 $323,000
Q1 2024

May 15, 2024

BUY
$68.14 - $84.23 $331,160 - $409,357
4,860 New
4,860 $345,000
Q3 2019

Nov 14, 2019

SELL
$83.55 - $100.0 $306,879 - $367,300
-3,673 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$77.76 - $95.7 $184,835 - $227,478
-2,377 Reduced 39.29%
3,673 $352,000
Q1 2019

May 14, 2019

SELL
$80.49 - $99.2 $264,329 - $325,772
-3,284 Reduced 35.18%
6,050 $534,000
Q4 2018

Feb 14, 2019

BUY
$74.64 - $97.62 $696,689 - $911,185
9,334 New
9,334 $775,000

Others Institutions Holding UTMD

About UTAH MEDICAL PRODUCTS INC


  • Ticker UTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 3,625,200
  • Market Cap $228M
  • Description
  • Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...
More about UTMD
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.